Incidence and prevalence of neurological disorders in the United Arab Emirates: a systematic review.
Incidence
Neurological disorders
Prevalence
UAE
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
03 Nov 2023
03 Nov 2023
Historique:
received:
19
09
2022
accepted:
23
10
2023
medline:
6
11
2023
pubmed:
4
11
2023
entrez:
4
11
2023
Statut:
epublish
Résumé
The United Arab Emirates (UAE) is a rapidly developing country. With the increase in average life-expectancy, high rates of consanguinity, and the adoption of a Western lifestyle, the burden of neurological disorders is expected to increase over the next few decades. Despite the importance of neurological disorders, there has not been a systematic review of published studies on the epidemiology of neurological disorders in the UAE. We searched for studies of incidence and/or prevalence of neurological disorders in the UAE published in English in MEDLINE, Google Scholar, Embase, and Scopus databases with no date restrictions up until 01 October 2023. Two authors independently assessed abstracts and full texts of possibly relevant papers, followed by data extraction from studies satisfying the eligibility criteria. Eight articles (N = 2067 patients) were included, half reported incidence and prevalence of multiple sclerosis, with an average crude prevalence 56/100,000 and related demyelinating disorders. Others were related to headache, meningitis, cerebral venous thrombosis, and brain tumours. There is a distinct lack of data on the epidemiology of different neurological diseases in the UAE. Large population-based studies, ideally longitudinal, are required to provide accurate and reliable estimates of the incidence and prevalence of neurological disorders to help inform healthcare capacity planning.
Sections du résumé
BACKGROUND/OBJECTIVES
OBJECTIVE
The United Arab Emirates (UAE) is a rapidly developing country. With the increase in average life-expectancy, high rates of consanguinity, and the adoption of a Western lifestyle, the burden of neurological disorders is expected to increase over the next few decades. Despite the importance of neurological disorders, there has not been a systematic review of published studies on the epidemiology of neurological disorders in the UAE.
METHODS
METHODS
We searched for studies of incidence and/or prevalence of neurological disorders in the UAE published in English in MEDLINE, Google Scholar, Embase, and Scopus databases with no date restrictions up until 01 October 2023. Two authors independently assessed abstracts and full texts of possibly relevant papers, followed by data extraction from studies satisfying the eligibility criteria.
RESULTS
RESULTS
Eight articles (N = 2067 patients) were included, half reported incidence and prevalence of multiple sclerosis, with an average crude prevalence 56/100,000 and related demyelinating disorders. Others were related to headache, meningitis, cerebral venous thrombosis, and brain tumours.
CONCLUSION
CONCLUSIONS
There is a distinct lack of data on the epidemiology of different neurological diseases in the UAE. Large population-based studies, ideally longitudinal, are required to provide accurate and reliable estimates of the incidence and prevalence of neurological disorders to help inform healthcare capacity planning.
Identifiants
pubmed: 37923997
doi: 10.1186/s12883-023-03446-6
pii: 10.1186/s12883-023-03446-6
pmc: PMC10623824
doi:
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
396Informations de copyright
© 2023. The Author(s).
Références
Neurology. 2014 Sep 9;83(11):1022-4
pubmed: 25200713
Mult Scler Relat Disord. 2020 May;40:101959
pubmed: 31991397
BMC Neurol. 2020 Aug 14;20(1):301
pubmed: 32795357
Clin Exp Neuroimmunol. 2018 Aug;9(3):155-161
pubmed: 30090123
Mult Scler Relat Disord. 2016 Sep;9:73-9
pubmed: 27645349
Int J Infect Dis. 2007 Jul;11(4):309-12
pubmed: 16950640
J Child Neurol. 2018 May;33(6):422-427
pubmed: 29607711
Int J Neurosci. 2011 Jul;121(7):393-8
pubmed: 21463177
Lancet Neurol. 2018 Nov;17(11):954-976
pubmed: 30353868
J Clin Epidemiol. 2009 Oct;62(10):1006-12
pubmed: 19631508
Syst Rev. 2015 Apr 19;4:52
pubmed: 25927506
Ann Neurosci. 2021 Jul;28(3-4):122-128
pubmed: 35341233
J Biosoc Sci. 1997 Oct;29(4):491-7
pubmed: 9881148
J Neurol Sci. 2009 Mar 15;278(1-2):1-4
pubmed: 19135686
BMC Cardiovasc Disord. 2015 May 07;15:30
pubmed: 25948543
Neuroepidemiology. 2016;46(3):209-21
pubmed: 26901651
Lancet Neurol. 2019 Apr;18(4):357-375
pubmed: 30773428
Headache. 2000 Feb;40(2):152-7
pubmed: 10759915
Glob Health Action. 2013 Feb 05;6:20100
pubmed: 23394856
Lancet Neurol. 2018 Nov;17(11):939-953
pubmed: 30287051
PLoS One. 2017 Jan 18;12(1):e0169949
pubmed: 28099445
Lancet Neurol. 2017 Nov;16(11):877-897
pubmed: 28931491
BMC Public Health. 2015 Feb 28;15:204
pubmed: 25885030
BMC Public Health. 2018 Jan 5;18(1):101
pubmed: 29304844
BMJ Open. 2020 Dec 17;10(12):e040166
pubmed: 33334833
Lancet Neurol. 2021 Oct;20(10):795-820
pubmed: 34487721
Lancet Neurol. 2019 Mar;18(3):269-285
pubmed: 30679040